Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
13C Octanoate Breath Test for NAFLD Severity
NCT01244503Phase 2Terminated
- Sponsor
- Virginia Commonwealth University
- Start
- Feb 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Octanoic acid in non-alcoholic fatty liver disease (NAFLD) and Nonalcoholic steatohepatitis (NASH), sponsored by Virginia Commonwealth University. Started Feb 2011; status: terminated.
02
Drugs
Octanoic acid
03
Conditions
non-alcoholic fatty liver disease (NAFLD)Nonalcoholic steatohepatitis (NASH)
Beyond the preview
Go deeper on NCT01244503.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01244503.